Atlas Trials

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

Clinical trial NCT00694096 · COMPLETED

Trial details

NCT number
NCT00694096
Sponsor
University of Utah
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell Cancer
Start date
2007-09-01
Primary completion
2014-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.